|
National Stock Number(NSN): 6505-01-250-3850 (6505012503850, 012503850)
| NIIN: |
01-250-3850 |
Item Name: |
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS1 |
INC: |
42704
|
| FSC: |
6505
|
Assignment Date: |
Feb-28-1987 |
CRIT: |
N |
IIG: |
42704 |
| ISC: |
2 |
Date Standardized: |
May-09-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-01-2004 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-0084 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
CALAN SR |
4N422
|
SEARLE G D AND CO R AND D DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
CALAN SR TABLETS |
4N422
|
SEARLE G D AND CO R AND D DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ISOPIN TABLETS |
04477
|
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
ISOPTIN SR |
04477
|
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00014-1891-60 |
4N422
|
SEARLE G D AND CO R AND D DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00044-1826-62 |
04477
|
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
Q |
U |
1 |
A |
$15.18 |
BT |
|
C2201X- |
Apr-01-1995 |
H |
| DF |
S9M |
Y |
|
Q |
U |
1 |
F |
$15.18 |
BT |
|
------- |
Jan-01-1997 |
H |
| DN |
S9M |
Y |
|
Q |
U |
1 |
N |
$15.18 |
BT |
|
9L----- |
Jan-01-1997 |
H |
| DS |
JDC |
L |
|
Q |
U |
1 |
D |
$15.18 |
BT |
|
------- |
Apr-01-1995 |
H |
| VA |
JVS |
I |
|
M |
U |
0 |
V |
$0.00 |
BT |
|
------- |
Jul-01-1991 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 60TT |
000 |
|
|
|
| DF |
Z |
DISCNT USE 6505-01-271-7667 |
000 |
|
|
|
| DN |
Z |
DISCNT USE 6505-01-271-7667 |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 60TT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 60TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
240.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJF |
LONG ACTION METHOD |
EXTENDED RELEASE |
| BLGJ |
COATING FEATURE |
FILM, NONENTERIC |
| CBBL |
FEATURES PROVIDED |
CHILD RESISTANT CLOSURE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
60.000 TABLETS |
| CSLH |
SCORING CHARACTERISTIC |
HALF-SCORED |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
4.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.13 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
12 |
| SUCB |
UNIT OF ISSUE CUBE |
0.11 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.33 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|